As drug prices keep rising, state lawmakers propose tough new bills to curb them
Salon.com· 5 days agoFed up with a lack of federal action to lower prescription drug costs, state legislators around the...
Major Advance in the Treatment of Axial Spondyloarthritis Coming
Medscape· 17 hours agoRheumatologists can look forward to the likely regulatory approval of the oral Janus kinase...
Elevate Your Thinking | RealClearPolitics
RealClearPolitics· 14 hours agoIf you've seen the signs reading, "Science is real," heard the phrase, "follow the science" or been told to "trust in science," and if these statements...
Analyst Report: Amgen Inc.
Morningstar Research via Yahoo Finance· 2 days agoAmgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship...
Top 15 Pharmaceutical Companies With Highest R&D Spending
Insider Monkey via Yahoo Finance· 2 days agoIn this article we are going to list the top 15 pharmaceutical companies with the highest R&D...
What a Juvenile Arthritis Diagnosis Really Means for Kids and Parents
Parents via Yahoo News· 3 days agoFor nineteen years I took our daughter Annierose to Boston Children's Hospital for joint taps, fever...
Amgen Wins Patent Case On Enbrel® (etanercept)
Trey Test Provider 001 via Yahoo News· 2 years ago(NASDAQ:AMGN) today announced that the U.S. District Court for the District of New Jersey has ruled in Amgen's favor on validity of the two patents that...
Pharmacy benefits manager Abarca inks discount deal for Amgen's Enbrel
Reuters via Yahoo News· 1 year agoPharmacy benefits managers like Abarca act as middlemen in the drug supply chain, and negotiate...
Amgen Wins Enbrel U.S. Patent Litigation Against Novartis
Zacks via Yahoo Finance· 2 years agoAmgen Inc. AMGN announced that a district court of New Jersey has upheld the validity of its two...
Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis
Reuters via Yahoo News· 2 years agoU.S. District Judge Claire Cecchi in Newark, New Jersey, rejected arguments by Novartis' Sandoz unit...